Julie Brooks, PMHNP | |
105 Windsor Path Ste 5, Georgetown, KY 40324-9819 | |
(859) 214-7440 | |
Not Available |
Full Name | Julie Brooks |
---|---|
Gender | Female |
Speciality | Nurse Practitioner - Psychiatric/mental Health |
Location | 105 Windsor Path Ste 5, Georgetown, Kentucky |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104538081 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | 3018760 (Kentucky) | Secondary |
363LP0808X | Nurse Practitioner - Psychiatric/mental Health | 3018760 (Kentucky) | Primary |
Entity Name | Psychological & Behavioral Consultants Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1811915713 PECOS PAC ID: 0446243760 Enrollment ID: O20160926002081 |
News Archive
Caring Brands International, which includes Interim HealthCare Inc., a national network of home care, hospice and health staffing franchises founded in 1966 and known for its continuum of care in the United States, today expands its global operations with the acquisition of Australia-based Just Better Care.
A rustle of undergrowth in the outback: it's a sound that might make an animal or person stop sharply and be still, in the anticipation of a predator. That "freezing" is part of the fear response, a reaction to a stimulus in the environment and part of the brain's determination of whether to be afraid of it.
The meta analysis, which examined more than 4.5 million data points on more than 100 microarrays from mouse models, also identified more than 1,300 functional groups, including signaling and transcription pathways, which may also play an important role in establishing a capacity for a "high level of alcohol consumption."
It's a common problem that only gets worse during the menopause transition; yet, no one wants to talk about it, and even fewer women are doing anything to correct it.
Stemedica Cell Technologies, Inc., a world leader in stem cell research and manufacturing, announced that it completed its pre-IND meeting with the U.S. Food and Drug Administration (FDA) regarding a proposed IND (Investigative New Drug) to evaluate the safety and efficacy of Stemedica's high potency proprietary allogeneic mesenchymal bone marrow-derived stem cells (adult human) as a treatment for ischemic stroke.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Julie Brooks, PMHNP 105 Windsor Path Ste 5, Georgetown, KY 40324-9819 Ph: (859) 214-7440 | Julie Brooks, PMHNP 105 Windsor Path Ste 5, Georgetown, KY 40324-9819 Ph: (859) 214-7440 |
News Archive
Caring Brands International, which includes Interim HealthCare Inc., a national network of home care, hospice and health staffing franchises founded in 1966 and known for its continuum of care in the United States, today expands its global operations with the acquisition of Australia-based Just Better Care.
A rustle of undergrowth in the outback: it's a sound that might make an animal or person stop sharply and be still, in the anticipation of a predator. That "freezing" is part of the fear response, a reaction to a stimulus in the environment and part of the brain's determination of whether to be afraid of it.
The meta analysis, which examined more than 4.5 million data points on more than 100 microarrays from mouse models, also identified more than 1,300 functional groups, including signaling and transcription pathways, which may also play an important role in establishing a capacity for a "high level of alcohol consumption."
It's a common problem that only gets worse during the menopause transition; yet, no one wants to talk about it, and even fewer women are doing anything to correct it.
Stemedica Cell Technologies, Inc., a world leader in stem cell research and manufacturing, announced that it completed its pre-IND meeting with the U.S. Food and Drug Administration (FDA) regarding a proposed IND (Investigative New Drug) to evaluate the safety and efficacy of Stemedica's high potency proprietary allogeneic mesenchymal bone marrow-derived stem cells (adult human) as a treatment for ischemic stroke.
› Verified 2 days ago